The innovative Vivally^® System is here and available for your OAB patients! The Vivally System is the first FDA-cleared, physiologic closed-loop wearable therapy that makes neuromodulation available to your patients without drugs or surgery.

The Vivally System sets a new standard in neuromodulation therapy by leveraging physiologic closed-loop transcutaneous tibial nerve stimulation (PCL-TTNS) with continuous EMG-sensing with companion mobile support application. Vivally is a physician-prescribed, at-home, wearable OAB therapy that can make a difference in as little as 30 minutes of use, one to three times a week, with symptom improvement and reduction in treatment frequency seen in as little as 12 weeks.

Renowned OAB expert, Michael J. Kennelly, MD, FPMRS, FACS, C. Emi Bretschneider, MD, and Jill Schiaparelli, CEO and Co-Founder of Avation Medical, will demonstrate how Vivally effectively manages symptoms of urge urinary incontinence and urinary urgency. From Vivally’s excellent clinical and safety outcomes and patient-friendly features to practical insights on patient selection, and efficiency in practice workflow, you’ll gain a clear understanding of how to offer this next-generation therapy to your patients.

Dr. Michael J. Kennelly is fellowship trained and board-certified urologist with subspecialty certification in female pelvic medicine and reconstructive surgery. Academically, he is a Professor in the Department of Urology at Carolinas Medical Center and at the University of North Carolina Medical School – Charlotte Campus and actively involved in the training of fellows and residents. Administratively, he is Medical Director of the Charlotte Continence Center at Carolinas Medical Center, Director of Urology at Carolinas Rehabilitation Hospital, and Co-Director of the Women’s Center for Pelvic Health. His interests are in the medical and surgical treatment of urinary incontinence and other types of voiding dysfunction, neuromodulation, prolapse repair, complex redo female urologic surgery, neurourology and fistula repair. He participates in numerous clinical trials and regularly serves as organizer, invited lecturer and visiting professor at local, national, and international events. Dr. Kennelly has authored or coauthored several journal articles, book chapters, and educational videos in the areas of urinary incontinence and neurourology and has lectured extensively on these topics. A Fellow of the American College of Surgeons, he is also a member of more than 15 professional organizations and holds several leadership positions. He is a Board of Director of the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction and Academy of Spinal Cord Injury Professionals. He is the current President of the Academy of Spinal Cord Injury Professionals, recent President of the American Paraplegic Society, Past President of the American Spinal Injury Association, in addition to recent Past Chairman of the Bladder Health Committee for the AUA Urology Care Foundation.

C. Emi Bretschneider, MD, joined the faculty of Northwestern University Feinberg School of Medicine’s Division of Urogynecology and Reconstructive Pelvic Surgery (URPS). Dr. Bretschneider is passionate about pelvic health. She believes that the most important part of the physician-patient relationship is communication and education. Her practice is centered on a collaborative approach to care with the goal of creating individualized plans to meet the unique concerns of each and every one of her patients.
​
Dr. Bretschneider completed her fellowship in Urogynecology and Reconstructive Pelvic Surgery at Cleveland Clinic in 2019 after completing her residency at the University of North Carolina School of Medicine. Dr. Bretschneider is an assistant professor of Obstetrics and Gynecology. She has a strong interest in both teaching and research. During her fellowship, Dr. Bretschneider focused her research pursuits on population-based database studies and was awarded a Cleveland Clinic Center for Population Health Research Grant. She also engaged in basic science research investigating the etiology of mesh complication in an animal model of prolapse for which she was awarded a Cleveland Clinic Research Program Committee Award.

Ms. Schiaparelli is passionate about bringing cutting-edge medical technologies to markets to help improve the lives of patients. With more than 20 years of experience in the healthcare industry, she has honed her expertise in leading innovative healthcare organizations, driving them to success with business strategy for healthcare technologies and care providers, specializing in global medical device commercialization, emerging technologies, strategic marketing, healthcare consumerism, and patient care pathway modeling.

Jill has held leadership roles with major healthcare companies such as Johnson & Johnson and Baxter as well as serving as an executive at high-growth, innovative companies such as ApaTech (UK), a company she helped sell to Baxter, AxoGen where she assisted their up-list to NASDAQ, InteloMed where she launched the CVInsight™ Monitoring and Informatics System, and Neurotechnology Innovations Translator, an incubator and investment vehicle to launch and grow companies in the neuromodulation space.

Jill has a MBA in Finance and Business Management from the Stern School of Business at New York University and a BS in Finance and International Management from the Questrom School of Business at Boston University.